Cargando…

Current and Future Potential Impact of COVID-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use

Kratom (Mitragyna speciosa Korth., Rubiaceae) is native to and has traditional use in Southeast Asia. The number of kratom users outside of Southeast Asia has increased significantly in recent decades with use spreading to the Unites States (US) and Europe. Because of its reputed opioid-like psychoa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Darshan, Brown, Paula N., Cinosi, Eduardo, Corazza, Ornella, Henningfield, Jack E., Garcia-Romeu, Albert, McCurdy, Christopher R., McMahon, Lance R., Prozialeck, Walter C., Smith, Kirsten E., Swogger, Marc T., Veltri, Charles, Walsh, Zach, Grundmann, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726130/ https://www.ncbi.nlm.nih.gov/pubmed/33324252 http://dx.doi.org/10.3389/fpsyt.2020.574483

Ejemplares similares

Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study
por: Metastasio, Antonio, et al.
Publicado: (2020)

Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance
por: Zhang, Mengzi, et al.
Publicado: (2022)

Lipid profile of regular kratom (Mitragyna speciosa Korth.) users in the community setting
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2020)

The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A Comprehensive Review
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2021)

Assessment of Cardiovascular Functioning Among Regular Kratom (Mitragyna speciosa Korth) Users: A Case Series
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2021)

Acute, Sublethal, and Developmental Toxicity of Kratom (Mitragyna speciosa Korth.) Leaf Preparations on Caenorhabditis elegans as an Invertebrate Model for Human Exposure
por: Hughes, Samantha, et al.
Publicado: (2022)

Kratom policy: The challenge of balancing therapeutic potential with public safety
por: Prozialeck, Walter C., et al.
Publicado: (2019)

Inhibition of α-Glucosidase and Pancreatic Lipase Properties of Mitragyna speciosa (Korth.) Havil. (Kratom) Leaves
por: Limcharoen, Thanchanok, et al.
Publicado: (2022)

Seasonal and Geographic Variation in Alkaloid Content of Kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand
por: Sengnon, Narumon, et al.
Publicado: (2023)

Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom)
por: Zhang, Mengzi, et al.
Publicado: (2020)

Kratom (Mitragyna speciosa)-Induced Hepatitis
por: Allison, Devin R., et al.
Publicado: (2022)

Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
por: Prevete, Elisabeth, et al.
Publicado: (2023)

Variations in mitragynine content in the naturally growing Kratom (Mitragyna speciosa) population of Thailand
por: Leksungnoen, Nisa, et al.
Publicado: (2022)

Accelerated Solvent Extractions (ASE) of Mitragyna speciosa Korth. (Kratom) Leaves: Evaluation of Its Cytotoxicity and Antinociceptive Activity
por: Goh, Yong Sean, et al.
Publicado: (2021)

Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review
por: Striley, Catherine W, et al.
Publicado: (2022)

Editorial: The Pharmacology of Kratom and Its Alkaloids
por: Grundmann, Oliver, et al.
Publicado: (2022)

A Case of Hyperkalemia Induced by Kratom (Mitragyna speciosa)
por: Torres-Ortiz, Aldo, et al.
Publicado: (2022)

Exploring of cardiac autonomic activity with heart rate variability in long-term kratom (Mitragyna speciosa Korth.) users: a preliminary study
por: Saengmolee, Wanumaidah, et al.
Publicado: (2022)

Association between kratom (Mitragyna speciosa) use and metabolic syndrome
por: La-up, Aroon, et al.
Publicado: (2022)

Leaf Anatomy and Micromorphology Characteristics of Ketum [Mitragyna speciosa (Korth.) Havil.] (Rubiaceae)
por: Ghazalli, Mohd Norfaizal, et al.
Publicado: (2021)

Kratom withdrawal: Discussions and conclusions of a scientific expert forum()
por: Henningfield, Jack E., et al.
Publicado: (2023)

Kratom (Mitragyna speciosa) and COVID-19: How about the current evidence?
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
por: Cinosi, Eduardo, et al.
Publicado: (2015)

Understanding Kratom Use: A Guide for Healthcare Providers
por: Swogger, Marc T., et al.
Publicado: (2022)

Investigating the Impact of Kratom (Mitragyna speciosa) Use Upon Male Sexual Health
por: Deebel, Nicholas A, et al.
Publicado: (2023)

Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa Korth in Sprague-Dawley Rats
por: Ilmie, Mohd U., et al.
Publicado: (2015)

Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
por: Ng, Jeremy Y., et al.
Publicado: (2021)

Assessment of the possible health risks associated with the consumption of botanical preparations of Mitragyna speciosa (kratom)
por: Papadi, Georgia, et al.
Publicado: (2022)

The evaluation of antinociceptive activity of alkaloid, methanolic, and aqueous extracts of Malaysian Mitragyna speciosa Korth leaves in rats
por: Sabetghadam, Azadeh, et al.
Publicado: (2010)

Comparative metabolomics analysis reveals alkaloid repertoires in young and mature Mitragyna speciosa (Korth.) Havil. Leaves
por: Veeramohan, Rubashiny, et al.
Publicado: (2023)

Effects of Mitragynine and a Crude Alkaloid Extract Derived from Mitragyna speciosa Korth. on Permethrin Elimination in Rats
por: Srichana, Kachamas, et al.
Publicado: (2015)

Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions
por: Todd, D. A., et al.
Publicado: (2020)

Ultrasound-assisted extraction conditions optimisation using response surface methodology from Mitragyna speciosa (Korth.) Havil leaves
por: Zakaria, Fazila, et al.
Publicado: (2021)

LC/ESI/TOF-MS Characterization, Anxiolytic and Antidepressant-like Effects of Mitragyna speciosa Korth Extract in Diabetic Rats
por: Chen, Lin, et al.
Publicado: (2022)

The Mitragyna speciosa (Kratom) Genome: a resource for data-mining potent pharmaceuticals that impact human health
por: Brose, Julia, et al.
Publicado: (2021)

Kratom ( Mitragyna speciosa ) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products
por: Manwill, Preston K., et al.
Publicado: (2022)

A Chromosome-Scale Genome Assembly of Mitragyna speciosa (Kratom) and the Assessment of Its Genetic Diversity in Thailand
por: Pootakham, Wirulda, et al.
Publicado: (2022)

The Potential for Kratom as an Antidepressant and Antipsychotic
por: Johnson, Lindsay E., et al.
Publicado: (2020)

Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants
por: Tanna, Rakshit S., et al.
Publicado: (2022)

In Vitro and in Vivo Effects of Three Different Mitragyna speciosa Korth Leaf Extracts on Phase II Drug Metabolizing Enzymes—Glutathione Transferases (GSTs)
por: Azizi, Juzaili, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nhum68g4unpsgependj28djena